Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Start Over |
Back to Previous Screen
Phosphate (Glycophos) Injection
Status: Currently in Shortage
» Date first reported:
» Therapeutic Categories: Gastroenterology; Pediatric; Total Parenteral Nutrition
Fresenius Kabi USA, LLC (Reverified 09/11/2014)
Company Contact Information
||Availability and Estimated Shortage Duration
||Shortage Reason (per FDASIA)
|Glycophos (sodium glycerophosphate) injection, 20 mL vial
Importation began May 2013. Please check wholesalers for inventory and reference Glycophos.
Currently backordered. Next release anticipated Q4 2014.
||Fresenius Kabi USA, LLC (FK USA) in conjunction with FDA has initiated temporary importation of Glycophos (sodium glycerophosphate) injection into the US market to address this shortage. Please see the Dear Healthcare Professional Letter (PDF - 443KB)20 for additional product and supply information. FK USA is releasing Glycophos to its authorized distributors.
Shortage per Manufacturer:
Increase in demand
Dear Healthcare Professional Letter